Skip to main content
ManagedFunds.nz

Fund-vs-fund · International Equities

Elevation Capital Global Shares Fund vs Smart Healthcare Innovation ETF

Both are International Equities funds available to NZ retail investors. Numbers below are sourced from the FMA Disclose register via Sorted Smart Investor and reflect the latest published quarterly fund updates.

Why these two differ

The most material structural difference between these two funds is their investment approach. The Smart Healthcare Innovation ETF (Smartshares) is a passthrough vehicle holding 99.91% of its assets in a single underlying instrument — the iShares Healthcare Innovation UCITS ETF — effectively concentrating all sector and single-ETF risk into one position. The Elevation Capital Global Shares Fund, by contrast, holds a diversified portfolio of individual equities, with its largest disclosed position (Rakon Ltd) at 8.59% and subsequent holdings spread across technology, consumer, and other global names.

Fee structures differ sharply: Smartshares discloses an annual fund charge of 0.75%, while Elevation Capital's is 1.80% — a 1.05 percentage point gap that compounds materially over time. Despite the higher cost, Elevation Capital's latest QFU reports a five-year return of 3.40% per annum, compared to Smartshares' 0.02% over the same period, though past returns are not a reliable indicator of future performance. Both funds carry a risk indicator of 6 out of 7 on the FMA's standardised scale.

Asset allocation also differs: Smartshares holds 98.31% in growth assets versus Elevation Capital's 78.34%, meaning the latter carries a modestly higher income or defensive component. Fund sizes are comparable — NZD 24.4 million and NZD 23.1 million respectively. Neither fund is a KiwiSaver scheme account product based on the disclosed data.

Always verify all figures against each fund's current Product Disclosure Statement and latest Quarterly Fund Update on FMA Disclose before relying on this summary.

Cached comparison generated 2026-05-21 from each fund's latest FMA Disclose QFU. Regenerated when the underlying facts change.

What's different at a glance

  • Smart Healthcare Innovation ETF charges 1.05% lower in annual fund charges (0.75% vs 1.80%).
  • Both are New Zealand PIE funds — investor tax is capped at the Prescribed Investor Rate (PIR), maximum 28%.

Where each fund sits in its cohort

Percentile rank vs all 81 international equities funds we've matched on Sorted Smart Investor. Mechanical only — no opinion, no forward-looking view.

Annual fund charge

Lower is better

Elevation Capital

1.80%

Highest 6% of cohort

Smartshares

0.75%

Upper half of cohort

5-year return p.a.

Past performance — not a predictor

Elevation Capital

3.40%

Bottom 15% over 5 years

Smartshares

0.19%

Bottom 1% over 5 years

Fund size

Larger = more stable, lower close-risk

Elevation Capital

NZ$23m

Smallest 20% in cohort

Smartshares

NZ$23m

Smallest 19% in cohort

Metric Elevation Capital Smartshares Lower / higher is
Annual fund charge 1.80% 0.75% Lower is better
Risk indicator (1–7) 6 6 Higher = more volatility
5-year return p.a. 3.40% 0.19% Higher is better
(past not future)
Fund size NZ$23m NZ$23m Larger = more stable, lower close-risk
Growth / income split 78% / 22% 98% / 2% More growth = higher long-run return + volatility
NZ tax structure PIE (PIR-capped) PIE (PIR-capped) PIE = simpler. FIF = annual return.
Currency hedging Hedged smooths NZD/foreign FX moves at a small cost.
Responsible investment screening No No Specific exclusions live in each fund's SIPO.
Available via Direct Direct Platforms accepting retail subscriptions.

Portfolio overlap

How many top-10 positions both funds hold, and at what weight. Computed from each fund's most recently disclosed top-10 holdings — exact-name matched (Microsoft Corp. = Microsoft Corporation), with a Cash / Cash & Equivalents collapse rule.

0 overlapping top-10 holdings. The two funds disclose disjoint top-10 sets — useful diversification signal if you held both.

What each fund says it does

Elevation Capital

Elevation Capital Global Shares Fund

The Fund mainly invests in the shares of listed companies, although it may invest in unlisted companies up to total limit of 10% of Net Asset Value of the Fund. The companies we invest in may be based and operate anywhere in the world. The principal objective of the Fund is to achieve positive absolute returns after fees and expenses, but before tax over the long term (that is a period of at least five years). The investment objectives and policy for the Fund are broadly drafted so as to provide us with the mandate to seek on behalf of investors long-term income
Full Elevation Capital Elevation Capital Global Shares Fund profile →

Smartshares

Smart Healthcare Innovation ETF

The Smart Healthcare Innovation ETF is designed to track the return (before tax, fees and other expenses) of the STOXX® Global Breakthrough Healthcare Index. The Index is comprised of stocks from developed and emerging market companies from sectors focused on pushing the boundaries in medical treatment technology.
Full Smartshares Smart Healthcare Innovation ETF profile →

Common questions

What's the difference between the Elevation Capital Global Shares Fund and the Smart Healthcare Innovation ETF?
Both are international equities funds available to NZ retail investors. Smart Healthcare Innovation ETF charges 1.05% lower in annual fund charges (0.75% vs 1.80%).
Which fund has lower fees, Elevation Capital Global Shares Fund or Smart Healthcare Innovation ETF?
Smart Healthcare Innovation ETF has the lower annual fund charge (0.75% p.a. vs 1.80% p.a.). Source: each fund's most recent Quarterly Fund Update on the FMA Disclose register.
How do the 5-year returns compare?
Elevation Capital Global Shares Fund's 5-year return p.a. is 3.40% and Smart Healthcare Innovation ETF's is 0.19% (after fees, before tax). Past performance is not a reliable indicator of future returns.
Are both funds PIE-taxed in NZ?
Yes. Both are NZ Portfolio Investment Entities (PIEs). Investor tax on the fund's income is capped at the Prescribed Investor Rate (PIR), maximum 28%.
Where can I read the official documents for these funds?
Both funds publish their Product Disclosure Statement (PDS), Statement of Investment Policy (SIPO) and Quarterly Fund Update (QFU) on the FMA Disclose register at disclose-register.companiesoffice.govt.nz. Always read the current PDS before investing.
FinanceAdvisers.co.nz logo
Not sure which fund is right for you?
Find a financial adviser on FinanceAdvisers.co.nz
Browse NZ-licensed financial advice providers and search by speciality, location and review.
Important: This comparison is general information only — not personalised financial advice. Past performance is not a reliable indicator of future returns. The right fund for you depends on your personal circumstances. Read each fund's Product Disclosure Statement and consider speaking to a licensed financial adviser.